Taplmmune Inc (TPIM) to Release Q4 2007 Earnings February 15

Taplmmune Inc (OTC:TPIM) will release the fourth quarter earnings for 2007 on February 15.

Formerly GeneMax Corp, Taplemmune is a biotechnology company that develops therapeutics to treat disorders such as cancer and infectious diseases.  The technology is based on the understanding TAP, a protein pump, which can be found in cells.  TAP is essential to the processing of freight antigens and used to eradicate the cancer or infected cell.

Company research is directed towards the development of immunotherapeutic and prophylactic vaccine products to treat cancer and protect against pathogenic microbes using TAP technology.

For more Earnings related events or to post your own events, visit:

http://events.finditt.com/Events_list.aspx?catid=13